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Background/aim: The objectives of this study were to assess pharyngeal airway volume (PAV) in patients with myotonic dystrophy type
1 (DM1) by cone-beam computerized tomography (CBCT) and to evaluate the impact of diaphragm thickness and pulmonary function
tests on PAV.
Materials and methods: Thirty DM1 patients (10 female and 20 male; mean age 42.40 ± 12.07) were included in the study. Age and
sex-matched thirty patients were participated as control group. In DM1 group pulmonary function tests (PFT) were performed.
Independent t-test was used to compare PAV values of patients with DM1 and control group. The Mann–Whitney U test was used to
compare the parameters according to sex (p < 0.05). Pearson and Spearman correlation tests were

used to evaluate the relationships
between parameters of DM1 patients (p < 0.05). A multiple linear regression analysis was performed to explain the PAV with parameters
that showed positive correlation with PAV.
Results: Age of onset and disease duration were 22.37 ± 8.45 and 20.03 ± 12.08, respectively, in patients with DM1. PAV values of control
group were significantly lower than DM1 group (p < 0.001). Forced expiratory volume in 1 s and forced volume vital capacity values
were higher in males than females in DM1 group according to sex (p < 0.001). PAV values were greater in male patients than females
of the DM1 group (p = 0.022). Diaphragm thickness in DM1 group after inspiration and expiration were 2.60 ± 0.65 and 1.94 ± 0.40,
respectively. According to the regression analysis, DTai and FVC were significantly explained the PAV.
Conclusion: PAV was higher in DM1 group. There was a significant positive correlation between diaphragm thickness, pulmonary
functions, and PAVs of DM1 patients. The amount of the PAV was mostly influenced by DTai and FVC. It is recommended to evaluate
the PAV in patients with DM1 because of impaired respiratory functions and pharyngeal muscle involvement.
Key words: Cone beam computed tomography, myotonic dystrophy type 1, pharyngeal airway, pulmonary function

1. Introduction
Myotonic dystrophy type 1 (DM1) inherited as an
autosomal dominant is a dynamic trinucleotide repeat
disease [1]. In DM1, which is a progressive and pleiotropic
disease, there is an unstable (CTG) reexpansion in the 3
‘untranslated region of the myotonic dystrophy protein
kinase (DMPK) gene on chromosome 19q13.3 [1]. The
prevalence of the disease, which is the most common type
of muscular dystrophy in adult age, is 0.5– 18.1 / 100.000
[2]. Clinical findings are characterized by multisystemic
findings such as muscle weakness, masticatory atrophy,
dysphagia, endocrinopathies, cardiac conduction defects,
cataracts, cholelithiasis, cognitive impairment, and
respiratory failure [3,4]. Reduced muscle strength and
motor function in a group of patients with DM1 was
shown by Kroksmark et al. [5].

Respiratory failure is one of the important factors
determining prognosis of DM1 [6]. During the followup period, the respiratory system should be evaluated
at regular intervals [6]. Alveolar hypoventilation
of respiratory muscles may cause weakness of the
pharyngeal muscles, which impact on both respiratory
and swallowing function [7–9]. Chewing / facial growth
pattern, obstructive sleep apnea syndrome (OSAS), and
pharyngeal airway volume (PAV) are closely related to
pharynx morphology [10]. Various studies in patients
with DM1 have evaluated muscular function, respiratory
function, and cognitive dysfunction [11–13]. However,
no study has assessed pharyngeal airways of patients with
DM1.
In the present study, taking into account the
involvement of the pharyngeal muscles, it was aimed to
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measure the pharyngeal airway volume (PAV) in patients
with DM1 with cone-beam computed tomography (CBCT)
and to evaluate the impact of diaphragm thickness (DTai:
diaphragm thickness after inspiration, DTae: diaphragm
thickness after expiration) and pulmonary function tests
((PFT) (FEV1: forced expiratory volume in 1 s and FVC:
forced volume vital capacity) on this parameter [14].
2. Materials and methods
2.1. Study population
This study was conducted in accordance with the principles
of the 1964 Helsinki Declaration and was approved by the
Non-Interventional Clinical Research Ethics Committee
of Çukurova University Faculty of Medicine (Protocol
no: 2020 / 95-45). A total of sixty adult individuals were
included in the present study. CBCT images of 30 patients
(20 males and 10 females) with DM1 and age- and sexmatched 30 healthy controls (20 males and 10 females)
were retrospectively evaluated from the archives of
the Oral and Maxillofacial Radiology Department of
Çukurova University. CBCT scans of both DM1 patients
and the control group were previously performed for
various dental reasons, so they were already available
in the archive of Department of Oral and Maxillofacial
Radiology. The control group included the individuals
with height and weight records, and, without tracheal and
lung diseases that affect the airway, any systemic disease
or use of any drugs that may affect respiratory parameters.
The standard protocol at Oral and Maxillofacial Radiology
Department contains acquiring signed informed consent
from all patients for evaluation of their CBCT records for
any reasons.
2.2. DM1 patients
The patients included to the study were diagnosed with
DM1 based on molecular studies at the Neuromuscular
Diseases outpatient clinic of Çukurova University
Faculty of Medicine, Department of Neurology. Up-todate information and previous test results of the patients
received from the supervisor of Neuromuscular Diseases
clinic. Age, sex, body mass index (BMI), age of onset (AO),
and disease duration (DD) of the patients were recorded.
Pulmonary function tests (PFT) were performed with
CareFusion micro RPM device. Diaphragm thickness
was measured in B-mode ultrasonography (USG) (GE,
logiq P6) with a high frequency (8-12 mHz) using linear
transducer at the end of the inspiration and expiration.
The thickness was measured from the two echogenic lines
(peritoneal line and pleural line).
2.3. Imaging procedure
The maxillofacial imaging of the patients was performed
with CBCT device (Planmeca ProMax 3D Mid, Helsinki,
Finland; exposure parameters: 90 kV, 10 mA, 27 sec scan

time, voxel size: 0.4 mm3) in Çukurova University Faculty
of Dentistry, Department of Oral and Maxillofacial
Radiology. As a standard CBCT imaging protocol, the
patients’ heads were positioned parallel to the horizontal
plane of the Frankfurt plane. The CBCT scans were
acquired while the patients closed their teeth in maximum
intercuspation. Images were evaluated using a 22-inch
LG Flatron monitor (LG, Seoul, Korea) set at a screen
resolution of 1440 × 900 pixel and 32-bit color depth.
2.4. Image analysis
Images in DICOM format were transferred to Dolphin 3D
software (version 11.95; Dolphin Imaging & Management
Solutions, Chatsworth, California). According to
Anandarajah et al., the upper limit according to the
pharyngeal airway boundaries was defined as the line
passing through the anterior nasal spina (ANS) and the
posterior nasal spina (PNS) points [15]. The lower border
was defined as the line passing through the supero-anterior
edge of the fourth cervical vertebra (C4) and the mentone
(Me) points. The anterior border was defined as the anterior
wall of the pharynx. The posterior border was defined as
posterior wall of the pharynx and the lateral borders were
defined as lateral pharyngeal walls. The most appropriate
threshold value for each patient was determined to cover
the maximum area by manually controlling the sagittal,
coronal, and axial sections, respectively, and then the
software automatically calculated the PAV (Figure 1a–1b).
Data were compared with the data of 30 age and sexmatched healthy control group patients.
2.5. Statistical analysis
Before the statistical analysis, the Kolmogorov–Smirnov
normality test was used to determine whether the data
were normally distributed. Independent t-test was
used to compare PAV values of
 patients with DM1 and
control group. The Mann–Whitney U test was used to
compare the parameters according to sex (p < 0.05).
Pearson and Spearman correlation testswere used to
evaluate the relationships between parameters of DM1
patients (p < 0.05). A multiple linear regression analysis
was performed to explain the PAV with parameters that
showed positive correlation with PAV. Radiological PAV
measurements were performed twice by two examiners
(BE, HD), two weeks apart and independently. Interrater
reliability was calculated with the intraclass correlation
coefficient (ICC). Pearson correlation coefficient (CC)
was used for intra-rater reliability. The ICCs and Pearson
CCs were greater than 0.90 for each comparison (p <
0.01). In this way, the calibration had been verified for
PAV. Mean values and standard deviations for parametric
distributed data, median and minimum-maximum values
for nonparametric distributed data are shown in the tables.
IBM SPSS software version 25.0 (IBM Corp., Armonk,
NY) statistical program was used for statistical analysis.
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Figure 1. Evaluation of pharyngeal airway volume in sagittal CBCT images (a) Determination of pharyngeal airway boundaries
in CBCT’s sagittal section. (b) 3D imaging of the pharyngeal airway volume CBCT, cone beam computed tomography; ANS:
anterior nasal spina; PNS: posterior nasal spina; C4: supero-anterior edge of fourth cervical vertebra; Me: menton.

3. Results
A total of 60 individuals, 30 DM1 (10 female /20 male)
patients with a mean age of 42.40 ± 12.07 were included in
the study. Thirty patients who were age and sex-matched
were included in the study as control group.
AO and DD were 22.37 ± 8.45 and 20.03 ± 12.08; the
measurements of DTai and DTae were 2.60 ± 0.65 and 1.94
± 0.40; FEV1 and FVC were 2.77 ± 1.22 and 3.33 ± 1.29
respectively, in patients with DM1 (Table 1).
The BMIs (p = 0.023) of the control group were
significantly higher than the DM1 group (p < 0.001), and
the PAV values were lower (p < 0.001) (Table 1).
FEV1 and FVC values were higher in males than
females in DM1 group in terms of sex (p < 0.001). While
the PAV values of the DM1 group were greater in male
patients than in female patients (p = 0.022), no significant
difference was found in the control group (Table 2).
A positive correlation was found between the DTai,
DTae, FEV1 and FVC values of DM1 patients and their
PAV values (p < 0.05) (Table 3). There was no correlation
between PAV and AO, DD, and BMI (Table 3).
Multiple linear regression analysis was performed to
develop a model that elucidates the PAV with parameters
(DTai, DTae, FEV1 ve FVC) that showed positive
correlation with PAV. The total variance of the PAV
explained by the regression model [F(4, 25) = 23.130, p <
0.001)] was 75.3% (R²adjusted was 0.753).
According to the analysis, DTai (ß = 0.311, t (25) =
2.620, p = 0.015, pr² = 0.215) and FVC (ß = 0.641, t (25) =
4.185, p < 0.001, pr² = 0.412) were significantly explained
the PAV. PAV was not significantly influenced by the DTae
and FEV1 according to regression model.
The predicted equation was as follows:
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PAV= –11417.25 + 4006.49*DTai + 3174.31*DTae –
762.73*FEV1 + 7836.55*FVC (Figure 2).
4. Discussion
Respiratory dysfunction is one of the most important
symptoms in DM1, which is the most common muscular
dystrophy in adults with multiple systemic involvements
[16,17]. In a recent study by Rossi et al., the restrictive
pulmonary disease was found in 51.9% of 251 DM1
patients [18]. They also stated that half of them needed
a non-invasive mechanical ventilator [18]. Various
studies were reporting that the causes of mortality in
DM1 patients are significantly related to respiratory
problems [19–21]. One of the most important parts of
the respiratory system is the upper respiratory tract.
Anatomical structures such as skeletal structures, muscles
surrounding the pharynx, and soft tissues determine the
size and configuration of the upper respiratory tract
[10,22]. Chewing / facial growth pattern, obstructive
sleep apnea syndrome (OSAS), and PAV are closely
related to pharynx morphology [10].
Despite greater hyoid bone excursion, patients with
DM1 generally have pharyngeal residue, and it often
takes a prolonged period of time to clear this residue
from the pharynx [23,24]. Decreased pressures in the
tongue and pharynx were observed in patients with DM1
[24]. Umemoto et al. have suggested that deterioration
of the masticatory and lingual muscles in patients with
DM1 completely impairs oropharyngeal function [24].
The present study focused on the evaluation of PAVs
of DM1 patients and detecting the impact of diaphragm
thickness and PFTs on PAV. It is thought that the
evaluation of the pharyngeal airway will be beneficial
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Table 1. Clinical parameters, diaphragm thickness, pulmonary function tests and
pharyngeal airway volume.
DM1 (N=30)

Control (N=30)

p

Age

42.40 ± 12.07

42.40 ± 12.07

1.000

BMI

24.56 ± 5.14

27.22 ± 3.51

0.023*

PAV

29082.60 ± 8407.63

18723.47 ± 3916.46

<0.001*

AO

22.37 ± 8.45

DD

20.03 ± 12.08

DTai

2.60 ± 0.65

DTae

1.94 ± 0.40

FEV1

2.77 ± 1.22

FVC

3.33 ± 1.29

The results are expressed as the mean ± standard deviation. * significant differences
between the groups. The independent samples t-test (*p < 0.05). AO: Age of onset.
BMI: Body mass index (kg/m2). DD: Disease duration. DM1: Myotonic dystrophy
Type 1. DTae: Diaphragm thickness after expiration. DTai: Diaphragm thickness after
inspiration. FEV1: Forced expiratory volume in 1 second. FVC: Forced volume vital
capacity. PAV: Pharyngeal airway volume (mm3).
Table 2. Clinical parameters, diaphragm thickness, pulmonary function tests, and
pharyngeal airway volume by sex.
DM1

Female (N=10)

Male (N=20)

p

Age

51 (25–69)

38.5 (19–57)

0.108

AO

20 (14–42)

18.5 (11–45)

0.675

DD

25.5 (10–45)

17.5 (2–38)

0.071

BMI

24.2 (20.2–34.1)

22.1 (18.7–30.8)

0.627

DTai

2.75 (1.7–3.4)

2.60 (1.5–4.3)

0.724

DTae

1.85 (1.1–2.6)

1.85 (1.2–2.8)

0.982

FEV1

1.06 (1.05–4.45)

3.13 (2.01–4.73)

0.021*

FVC

1.39 (1.38–5.03)

3.63 (2.76–5.93)

0.012*

PAV

22635 (13409–36418)

34065 (13561–43820)

0.022*

Control

Female (N=10)

Male (N=20)

p

Age

51 (25–69)

38.5 (19–57)

0.108

BMI

23.8 (19.4–28)

28.7 (20.5–32.1)

0.001*

PAV

18101 (11068–23883)

19127 (13372–27153)

0.538

The results are expressed as the median (minimum–maximum). * indicate the significant
differences between groups. The Mann–Whitney U test (*p < 0.05). AO: Age of onset. BMI:
Body mass index (kg/m2). DD: Disease duration. DM1: Myotonic dystrophy Type 1. DTae:
Diaphragm thickness after expiration. DTai: Diaphragm thickness after inspiration. FEV1:
Forced expiratory volume in 1 second. FVC: Forced volume vital capacity. PAV: Pharyngeal
airway volume (mm3).

for clinicians due to impaired respiratory functions and
pharyngeal muscle involvement in DM1 patients.
Generally, lateral cephalogram was used in the studies
evaluating the pharyngeal airway [25]. However, the

cephalometric technique, which has various disadvantages
such as low repeatability, distortion, superposition, and
magnification due to landmark identification problems
[25] is not a suitable method for volume assessment since

3025

EVLİCE et al. / Turk J Med Sci
Table 3. Correlations between clinical parameters, diaphragm thickness, pulmonary function tests and PAV
of DM1 patients
AO

DD

BMI

DTai

DTae

FEV1

FVC

PAV

DD

–0.362*

1

0.469**

0.031

–0.209

–0.321

–0.394*

–0.305

p

0.050

.

0.009

0.870

0.269

0.083

0.031

0.101

BMI

0.034

0.469**

1

–0.083

–0.093

–0.279

–0.418*

–0.312

p

0.860

0.009

.

0.663

0.623

0.135

0.021

0.093

DTai

–0.194

0.031

–0.083

1

0.533**

0.122

0.154

0.681**

p

0.305

0.870

0.663

.

0.002

0.521

0.418

<0.001

DTae

–0.166

–0.209

–0.093

0.533**

1

0.673**

0.646**

0.679**

p

0.380

0.269

0.623

0.002

.

<0.001

<0.001

<0.001

FEV1

–0.386*

–0.321

–0.279

0.122

0.673**

1

0.766**

0.641*

p

0.035

0.083

0.135

0.521

<0.001

.

<0.001

<0.001

FVC

–0.298

–0.394*

–0.418*

0.154

0.646**

0.766**

1

0.831*

p

0.110

0.031

0.021

0.418

<0.001

<0.001

.

<0.001

PAV

–0.236

–0.305

–0.312

0.681**

0.679**

0.641*

0.831*

1

p

0.208

0.101

0.093

<0.001

<0.001

<0.001

<0.001

.

Regression Standardized Predicted Value

*Correlation is significant at the 0.05 level. **Correlation is significant at the 0.01 level (Pearson and
Spearman correlations, two-tailed). AO: Age of onset. BMI: Body mass index (kg/m2). DD: Disease
duration. DM1: Myotonic dystrophy Type 1. DTae: Diaphragm thickness after expiration. DTai: Diaphragm
thickness after inspiration. FEV1: Forced expiratory volume in 1 second. FVC: Forced volume vital capacity.
PAV: Pharyngeal airway volume (mm3).
Scatterplot
Dependent Variable: Pharyngeal Airway Volume
2

1

0

-1

-2
-3

-2

-1

0

1

2

3

Regression Standardized Residual

Figure 2. The predicted equation: PAV= –11417.25 + 4006.49*DTai + 3174.31*DTae
– 762.73*FEV1 + 7836.55*FVC. DTae: Diaphragm thickness after expiration. DTai:
Diaphragm thickness after inspiration. FEV1: Forced expiratory volume in 1 second.
FVC: Forced volume vital capacity. PAV: Pharyngeal airway volume.

it is a two-dimensional imaging method [26]. With CBCT,
which is a three-dimensional imaging method, the oral
and maxillofacial complex has been evaluated in detail
with many sections [27–29]. CBCT attracted researchers
because of its accurate 3D reconstruction and high image
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quality presentation [30]. In addition, CBCT has a much
lower radiation dose than and faster scanning time
compared to computed tomography (CT) [27]. It had been
considered an acceptable, effective, and simple imaging
method for PAV measurement [22,31,32].

EVLİCE et al. / Turk J Med Sci
Increased PAV in DM1 may manifest as an adaptation in
response to impaired respiratory functions and diaphragm
thickness [33]. It is known that pharyngeal airway volumes
increase in OSAS patients, especially with mandibular
advancement operations [33]. In the present study, PAV
values of DM1 patients were significantly higher than the
control group (p < 0.001).
Respiratory problems are one of the major problems in
DM1 patients [34]. Although the prevalence of sleep apnea
has been reported between 15.8% and 75%, to the best of
our knowledge, there were no studies examining airway
volumes in DM1 patients [33–35]. Although there was no
statistically significant difference in PAV values between
sexes in the control group, PAV was significantly higher
in male patients in the DM1 group (p = 0.022). It was
thought that this may be due to the fact that pharyngeal
airways in male patients in the DM1 group show more
adaptive changes to impaired respiratory functions. This
situation can be clarified by further studies examining the
relationship between airways and other factors that may be
predisposing.
The diaphragm is the main inspiratory pump muscle
and works together with the pharyngeal respiratory
muscles to maintain airway patency [36]. USG which
has many advantages such as lack of ionizing radiation,
ease of application, high spatial resolution, and dynamic
imaging, can be used to measure diaphragm thickness in
neuromuscular and pulmonary diseases [37,38]. Therefore,
it was also used to evaluate the diaphragm muscles of the
patients included in the present study. In previous studies,
it was reported that the diaphragm thickness measured by
USG was significantly lower in patients with DM1 [39,40].
One of the indicators of lung functions is considered
to be PFT (FEV1, FVC) values [41]. While Henke et al.
reported lower FVC value and FEV1 / FVC ratio [39]; Koc
et al. reported lower FEV1 and FVC values in DM1 patients
[40]. These results show that the lung function of DM1
patients isimpaired compared to the normal population. In
addition, the PFT (FEV1, FVC) values of male patients in
DM1 group were higher than those of female patients.
The positive correlation between PAV and DTai, DTae,
FEV1, and FVC indicated that a regression analysis can be

carried out. The amount of the PAV was mostly influenced
by DTai and FVC. PAV was not significantly influenced by
the DTae and FEV1 according to regression model. Further
studies should be encouraged on the reasons of these
different relations.
The conditions such as functional exercise capacity
and inactivity of DM1 patients were not evaluated in the
present study. Considering that this situation may affect the
respiratory muscles and thus the airway volume, further
studies can be planned on this subject. Another limitation
of the present study was the difference of BMIs between the
study groups. BMIs of the control group were significantly
higher than those of the DM1 group. Bhatti et al. found
that there is significant association between BMI and
pulmonary function parameters. They stated that obesity
has detrimental effects on respiratory system. Therefore,
the results of the present study could have been affected by
this situation [42].
The present study was the first study to use CBCT to
evaluate the PAV of DM1 patients. In DM1 group, PAV was
higher compared to control group. There was a significant
positive correlation between the PAV values 
of DM1
patients and their diaphragm thickness and PFT values (p

< 0.05). However, it was revealed that DTai and FVC had a
considerable influence on PAV according to the regression
analysis. It is recommended to evaluate the pharyngeal
airway in DM1 patients because of impaired respiratory
functions and pharyngeal muscle involvement.
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